NY-ESO-1 expression in solid tumors predicts prognosisHuiyu Wang, Chaoying Liu, Junying Xu et al.|Medicine|2019Cited by 18
High-dose fulvestrant as third-line endocrine therapy for breast cancer metastasis to the left kidneyDandan Xia, Junying Xu, Chaoying Liu et al.|Medicine|2018Cited by 2
NEUROD1 predicts better prognosis in pancreatic cancer revealed by a TILs-based prognostic signatureZhiyang Jiang, Junli Ding, Jiadong Pan et al.|Frontiers in Pharmacology|2022Cited by 2